ストックスクリーナーアプリを入手
2.17
1.36%
-0.03
アフターアワーズ：
2.04
-0.13
-5.99%
前日終値:
$2.20
開ける：
$2.13
24時間の取引高:
94,117
Relative Volume:
0.07
時価総額：
$66.70M
収益：
-
当期純損益:
$-19.54M
株価収益率:
-1.6602
EPS:
-1.3071
ネットキャッシュフロー:
$-21.18M
1週間 パフォーマンス:
+367.27%
1か月 パフォーマンス:
+172.96%
6か月 パフォーマンス:
+247.76%
1年 パフォーマンス:
-31.55%
1日の値動き範囲:
$2.09
$2.25
1週間の範囲:
$2.00
$2.4727
52週間の値動き範囲:
$0.44
$7.20
Calcimedica Inc Stock (CALC) Company Profile
Compare CALC vs VRTX, REGN, ARGX, MRNA, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
2.17 | 17.93M | 0 | -19.54M | -21.18M | -1.3071 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc (CALC) 最新ニュース
CalciMedica (CALC) grants director 10,000 stock options through 2036 - Stock Titan
CalciMedica (NASDAQ: CALC) awards director 10,000 options at $0.61 - Stock Titan
CalciMedica (CALC) grants director 10,000 stock options at $0.61 - Stock Titan
CalciMedica (CALC) director granted 2.9M-share warrants with 9.99% cap - Stock Titan
CalciMedica (NASDAQ: CALC) grants FDA-linked warrants capped at 19.99% stake - Stock Titan
CalciMedica (NASDAQ: CALC) CEO granted new stock warrants - Stock Titan
CalciMedica (NASDAQ: CALC) has 9.99% holder blocked from using more warrants - Stock Titan
CalciMedica (CALC) Financial Update: EPS Lands Above Forecast in the Current Update; The Stock Ends Down 4.88% in the Current UpdateProfit Inflection Point - vinanet.vn
ARMISTICE CAPITAL, LLC Acquires Significant Stake in CalciMedica Inc (CALC) - GuruFocus
CalciMedica Shareholders Approve Reverse Stock Split - Minichart
CalciMedica Shareholders Approve Key Equity and Governance Changes - TipRanks
CalciMedica (NASDAQ: CALC) holders back reverse split and warrant deals - Stock Titan
Guggenheim initiates CalciMedica stock coverage with buy rating By Investing.com - Investing.com India
Guggenheim initiates CalciMedica stock with buy rating on drug potential - Investing.com
CalciMedica (CALC) Edges Higher by 2.71% as Shares Consolidate Between $0.65 and $0.71TRIN Signal - dars.gov.et
Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power - Stock Titan
Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica - Stock Titan
CALC Q1 2026 Earnings: EPS of $0.30 Crushes Estimates, Stock Advances 6%Revenue Miss Report - vinanet.vn
CALC Q1 2026 Earnings: EPS Swings to Profit With 205.04% SurpriseEarnings Sentiment Score - vinanet.vn
CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com
CalciMedica shares see H.C. Wainwright neutral rating reiterated By Investing.com - Investing.com Canada
Price to book forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
Price to book forward of CalciMedica, Inc. – BOATS:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – NASDAQ:CALC - tradingview.com
Price to sales forward of CalciMedica, Inc. – BOATS:CALC - TradingView
CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 8K CalciMedica Inc For: 11 August By Investing.com - Investing.com UK
CalciMedica, Inc. 2Q 2026: Net loss $7.7M, EPS $(0.45) — 10-Q Summary - TradingView
CalciMedica (CALC) cuts expenses, raises $15M but flags going concern risk - Stock Titan
CalciMedica Releases Q2 2026 Financial Results - AlphaStreet
CalciMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss - Yahoo Finance
CalciMedica Secures Up To $49 Million Private Placement To Advance Pulmonary Hypertension Pipeline - Minichart
CalciMedica Inc reports results for the quarter ended June 30Earnings Summary - TradingView
CalciMedica Q2 FY26 net loss widens to $7.65 million - Bitget
CalciMedica stock gains 6% despite earnings miss on pulmonary trial By Investing.com - Investing.com South Africa
CalciMedica stock gains 6% despite earnings miss on pulmonary trial - Investing.com
CalciMedica reports Q2 2026 results: $18.6M cash, net loss $7.7M; financing to fund PH programs - TradingView
CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - Moomoo
CalciMedica Q2 Results: EPS misses estimate, losses widen 12.5% YoY - scanx.trade
CalciMedica Inc (CALC) Stock News Today - TradingKey
CalciMedica Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
CalciMedica, Inc. SEC Filing (Aug 3, 2026) - Stock Titan
CalciMedica Inc (CALC:UR): Stock Price, Quote and News - bnnbloomberg.ca
CalciMedica aligns with FDA on acute pancreatitis trial design By Investing.com - Investing.com Canada
CalciMedica Announces FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints - PR Newswire
CalciMedica Inc (CALC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CalciMedica Inc (CALC) Institutional Confidence - TradingKey
CALC|CalciMedica Inc|Price:0.760|Chg%:+0.044 - TradingKey
CalciMedica Inc (CALC) Cash Flow - TradingKey
CalciMedica Inc (CALC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Calcimedica Inc (CALC) 財務データ
収益
当期純利益
現金流量
EPS
Calcimedica Inc (CALC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 18 '25 |
Buy |
3.07 |
2,500 |
7,675 |
84,150 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 15 '25 |
Buy |
2.68 |
3,400 |
9,105 |
81,650 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 12 '25 |
Buy |
3.12 |
5,000 |
15,600 |
78,250 |
| Roberts Eric W | CHIEF BUSINESS OFFICER |
Sep 09 '25 |
Buy |
3.15 |
2,343 |
7,378 |
73,250 |
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):